Yuefeng Du
Impact in
- Urology top 5%
- Urinary Bladder and Prostate Research
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Circular RNAs in diseases 4
- Epigenetics and DNA Methylation 4
-
- MicroRNA in disease regulation 7
- Cancer-related molecular mechanisms research 4
- Co-authors
- Qingzhi Long (14 shared papers)Dalin He (13 shared papers)Lijun Mu (12 shared papers)Juanhua Tian (10 shared papers)Dapeng Wu (7 shared papers)Bin Guan (3 shared papers)Yumei Jiang (7 shared papers)Xinyang Wang (7 shared papers)
- Journals
- Anti-Cancer Agents in Medicinal Chemistry (2 papers)Oncology Reports (2 papers)Cancer Letters (1 paper)Advanced Science (1 paper)Scientific Reports (1 paper)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Yuefeng Du
34 papers receiving 774 citations
Peers
Comparison fields: 5 of 76
- Urology 76
- Cancer Research 177
- Molecular Medicine 39
- Pulmonary and Respiratory Medicine 166
- Molecular Biology 366
Countries citing papers authored by Yuefeng Du
This map shows the geographic impact of Yuefeng Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuefeng Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuefeng Du more than expected).
Fields of papers citing papers by Yuefeng Du
This network shows the impact of papers produced by Yuefeng Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuefeng Du. The network helps show where Yuefeng Du may publish in the future.
Co-authors
The 25 scholars most cited alongside Yuefeng Du, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 103 | |
| 2 | 2015 | 85 | |
| 3 | 2018 | 85 | |
| 4 | 2016 | 54 | |
| 5 | 2012 | 45 | |
| 6 | 2014 | 34 | |
| 7 | 2016 | 32 | |
| 8 | 2012 | 31 | |
| 9 | 2008 | 31 | |
| 10 | 2015 | 30 | |
| 11 | 2013 | 29 | |
| 12 | 2020 | 24 | |
| 13 | 2016 | 22 | |
| 14 | 2018 | 22 | |
| 15 | 2020 | 21 | |
| 16 | 2015 | 21 | |
| 17 | 2015 | 15 | |
| 18 | 2020 | 11 | |
| 19 | 2015 | 11 | |
| 20 | 2020 | 8 |
About Yuefeng Du
Yuefeng Du is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Oncology and Urology, having authored 35 papers that have together received 778 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (7 papers), Circular RNAs in diseases (4 papers), Urinary Bladder and Prostate Research (4 papers), Epigenetics and DNA Methylation (4 papers), Cancer-related molecular mechanisms research (4 papers), Sperm and Testicular Function (3 papers), Prostate Cancer Diagnosis and Treatment (3 papers) and Chemokine receptors and signaling (3 papers). The work is most often cited by research in Urology (76 citations), Cancer Research (177 citations), Molecular Medicine (39 citations), Pulmonary and Respiratory Medicine (166 citations) and Molecular Biology (366 citations). Yuefeng Du has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Qingzhi Long, Dalin He, Lijun Mu, Juanhua Tian, Dapeng Wu, Bin Guan, Yumei Jiang, Xinyang Wang, Xudong Li and Kaijie Wu. Their work appears in journals such as Anti-Cancer Agents in Medicinal Chemistry, Oncology Reports, Cancer Letters, Advanced Science and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.